Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease...
8 insider purchases on record · latest filing 2026-08-14.
Insiders have also filed 6 sale transactions at PFSA.